Kestra Advisory Services, LLC Edwards Lifesciences Corp Transaction History

Kestra Advisory Services, LLC

$17.2 Billion
Q4 2024

A detailed history of Kestra Advisory Services, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 12,294 shares of EW stock, worth $891,069. This represents 0.01% of its overall portfolio holdings.

Number of Shares

12,294

Previous 16,480 25.4%

Holding current value

$891,069

Previous $1.09 Million 16.28%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$64.54 - $75.92 $270,164 - $317,801	-4,186 Reduced 25.4%	12,294 $910,000
Q3 2024 Nov 13, 2024	SELL	$59.7 - $93.78 $387,512 - $608,725	-6,491 Reduced 28.26%	16,480 $1.09 Million
Q2 2024 Aug 14, 2024	BUY	$84.3 - $94.31 $104,110 - $116,472	1,235 Added 5.68%	22,971 $2.12 Million
Q1 2024 May 15, 2024	BUY	$72.54 - $95.56 $100,758 - $132,732	1,389 Added 6.83%	21,736 $2.08 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $10,243 - $12,908	166 Added 0.82%	20,347 $1.55 Million
Q3 2023 Nov 09, 2023	BUY	$69.28 - $93.38 $291,045 - $392,289	4,201 Added 26.29%	20,181 $1.4 Million
Q2 2023 Aug 11, 2023	SELL	$81.41 - $94.33 $199,291 - $230,919	-2,448 Reduced 13.28%	15,980 $1.51 Million
Q1 2023 May 12, 2023	SELL	$74.26 - $84.51 $1.64 Million - $1.86 Million	-22,040 Reduced 54.46%	18,428 $1.52 Million
Q4 2022 Jan 31, 2023	BUY	$68.3 - $87.44 $336,514 - $430,816	4,927 Added 13.86%	40,468 $3.02 Million
Q3 2022 Nov 01, 2022	BUY	$82.37 - $107.29 $530,133 - $690,518	6,436 Added 22.11%	35,541 $2.94 Billion
Q2 2022 Aug 12, 2022	BUY	$86.5 - $128.27 $464,159 - $688,296	5,366 Added 22.6%	29,105 $2.77 Million
Q1 2022 Apr 26, 2022	BUY	$101.96 - $128.34 $137,442 - $173,002	1,348 Added 6.02%	23,739 $2.79 Million
Q4 2021 Jan 20, 2022	SELL	$106.37 - $130.68 $128,175 - $157,469	-1,205 Reduced 5.11%	22,391 $2.9 Million
Q3 2021 Oct 19, 2021	BUY	$102.91 - $122.75 $143,044 - $170,622	1,390 Added 6.26%	23,596 $2.67 Million
Q2 2021 Jul 28, 2021	SELL	$83.84 - $104.76 $5,030 - $6,285	-60 Reduced 0.27%	22,206 $2.3 Million
Q1 2021 May 10, 2021	BUY	$78.68 - $90.67 $805,053 - $927,735	10,232 Added 85.03%	22,266 $1.86 Million
Q4 2020 Jan 20, 2021	BUY	$71.69 - $91.23 $854,042 - $1.09 Million	11,913 Added 9845.45%	12,034 $1.08 Billion
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $8,129 - $10,580	121 New	121 $655 Million

Others Institutions Holding EW

# of Institutions

1,384

Shares Held

454M

Call Options Held

6.71M

Put Options Held

3.17M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $44.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.

Account

Kestra Advisory Services, LLC Edwards Lifesciences Corp Transaction History